Bladder Cancer Trial, Recruiting NCT07379281 Sponsor: Qilu Hospital of Shandong University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07379281
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old (any gender)
  • You have been diagnosed with muscle-invasive bladder cancer (a stage where the cancer has grown into the muscle wall of the bladder) that has not spread to distant parts of the body, and your doctor has recommended chemotherapy before surgery
  • You have not previously received any chemotherapy treatment delivered throughout your whole body (systemic chemotherapy)
  • Your doctor has determined you are well enough to tolerate a chemotherapy treatment that includes a platinum-based drug
  • Your general health and ability to carry out daily activities is at an acceptable level (confirm with trial site)
  • You are able and willing to follow the trial's requirements, attend check-ups, and report any side effects
  • You are willing to take part voluntarily and have signed a consent form after being informed about the study

Who may not be able to join:

  • Your bladder cancer has reached a very advanced local stage (T4b) or has spread to other parts of the body, or your doctor feels you would not be able to safely undergo bladder removal surgery
  • You have a weakened or damaged immune system (for example, due to HIV/AIDS, or because you are taking medications that suppress the immune system, or receiving radiotherapy)
  • You have a known allergy to any of the study drugs or similar medicines or their ingredients
  • You have been taking hormone-based medications long-term, or have a history of drug misuse or dependence
  • You are pregnant, breastfeeding, or planning to become pregnant in the near future
  • Your blood test results show abnormalities in areas such as blood cell counts, liver function, kidney function, or blood clotting — including things like low white blood cell or platelet counts, low haemoglobin (anaemia), poor kidney filtering ability, or abnormal clotting measurements (confirm with trial site for specific thresholds)
  • You have been previously diagnosed with a bone marrow disorder called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukaemia (AML)
  • You have a confirmed history of a significant neurological or psychiatric condition, such as epilepsy or dementia
  • You have other serious ongoing health conditions — such as poorly controlled high blood pressure, diabetes, or thyroid disease — that could put you at risk or affect your ability to complete the study
  • You have an active, uncontrolled infection, serious heart problems (such as heart failure, unstable chest pain, or irregular heartbeat), or other serious illnesses requiring additional treatment
  • Your personal or family circumstances may make it difficult to safely participate or for the trial team to collect necessary information (confirm with trial site)
  • Your doctor or the trial investigator feels for any other reason that this trial is not appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18560084873

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

One-year OS ,Three-year OS and five-year OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov